|
Advisory Board Members
The detailed investment strategy and the exact approach of the fund concept are currently being worked out with the support of a prestigious advisory board.
- John Cheesemond, Member of the Supervisory Board, Cognis
- Walter Groll, Member of the Board of Management, DekaBank
- Prof. Dr. Josef Nassauer, Chief Executive, Bayern Innovativ
- Dr. Achim Riemann, CEO of International Chemical Investors and previously CEO of Arthur D. Little in Central Europe
- Thomas Schäfer, Senior Director New Business Development, Novozymes
- Dr. Klaus Warning, Business Angel with c-LEcta and previously Member of the Board at Hoechst Celanese and SGL Carbon
|